Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings

Edwards Lifesciences Corp. EW is scheduled to report second-quarter 2025 results on July 24, after market close.In the last reported quarter, the company’s adjusted earnings per share of 64 cents beat the Zacks Consensus Estimate by 6.67%. Its earnings beat estimates in two of the trailing four quarters and matched...